Fei Yi

机构：Nanchang University, Second Affiliated Hospital of Nanchang University · ORCID：0009-0002-7049-9196

发表论文 7 篇 · 总被引 122 次 · h-index 3

代表论文

• Sublingual Edaravone Dexborneol for the Treatment of Acute Ischemic Stroke (2024 · JAMA Neurology · 被引 97)
• Albiflorin relieves cerebral ischemia-reperfusion injury by activating Nrf2/HO-1 pathway. (2023 · PubMed · 被引 15)
• Research on the mechanism of regulating spleen-deficient obesity in rats by bawei guben huashi jiangzhi decoction based on multi-omics analysis (2024 · Journal of Ethnopharmacology · 被引 7)
• Sublingual Edaravone Dexborneol for the Treatment of Acute Ischemic Stroke (TASTE-SL): A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial (2023 · SSRN Electronic Journal · 被引 1)
• [Effects of cinepazide maleate injection on blood pressure in patients with acute ischemic stroke and hypertension]. (2022 · PubMed · 被引 1)
• Efficacy and safety of cinepazide maleate injection in patients with acute ischemic stroke: A multicenter, randomized, double-blind, placebo-controlled trial (2020 · Research Square · 被引 1)